These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Impact of delayed systemic heparinization on postoperative bleeding and thromboembolism during post-cardiotomy extracorporeal membrane oxygenation in neonates. von Stumm M; Subbotina I; Biermann D; Gottschalk U; Mueller G; Kozlik-Feldmann R; Reichenspurner H; Riso A; Sachweh JS Perfusion; 2020 Oct; 35(7):626-632. PubMed ID: 32072861 [TBL] [Abstract][Full Text] [Related]
6. A filter device for the prevention of both heparin- and protamine-induced complications associated with extracorporeal therapy. Yang VC; Teng CL; Kim JS Biomed Instrum Technol; 1990; 24(6):433-9. PubMed ID: 2261582 [TBL] [Abstract][Full Text] [Related]
7. Extracorporeal membrane oxygenation without anticoagulation: a study using quantitative scanning electron microscopy. Kundu SK; Salley SO; Whittlesey GC; Klein MD J Lab Clin Med; 1989 Jul; 114(1):58-62. PubMed ID: 2738449 [TBL] [Abstract][Full Text] [Related]
8. Activation of the clotting system: heparin-coated versus non coated systems for extracorporeal circulation. Urlesberger B; Zobel G; Rödl S; Dacar D; Friehs I; Leschnik B; Muntean W Int J Artif Organs; 1997 Dec; 20(12):708-12. PubMed ID: 9506788 [TBL] [Abstract][Full Text] [Related]
9. Attenuation of hemodynamic and hematologic effects of heparin-protamine sulfate interaction after aortic reconstruction in a canine model. Wakefield TW; Lindblad B; Whitehouse WM; Hantler CB; Stanley JC Surgery; 1986 Jul; 100(1):45-51. PubMed ID: 3726760 [TBL] [Abstract][Full Text] [Related]
10. The use of immobilized protamine in removing heparin and preventing protamine-induced complications during extracorporeal blood circulation. Yang VC; Port FK; Kim JS; Teng CL; Till GO; Wakefield TW Anesthesiology; 1991 Aug; 75(2):288-97. PubMed ID: 1859016 [TBL] [Abstract][Full Text] [Related]
11. Inactivation of heparin during extracorporeal circulation in infants. Green TP; Isham-Schopf B; Irmiter RJ; Smith C; Uden DL; Steinhorn RH Clin Pharmacol Ther; 1990 Aug; 48(2):148-54. PubMed ID: 2379386 [TBL] [Abstract][Full Text] [Related]
12. Lepirudin in heparin-induced thrombocytopenia and extracorporeal membranous oxygenation. Dager WE; Gosselin RC; Yoshikawa R; Owings JT Ann Pharmacother; 2004 Apr; 38(4):598-601. PubMed ID: 14982973 [TBL] [Abstract][Full Text] [Related]
13. Ex vivo testing of heparin-coated extracorporeal circuits: bovine experiments. Weerwind PW; van der Veen FH; Lindhout T; de Jong DS; Cahalan PT Int J Artif Organs; 1998 May; 21(5):291-8. PubMed ID: 9684912 [TBL] [Abstract][Full Text] [Related]
14. Activated partial thromboplastin time is a better trending tool in pediatric extracorporeal membrane oxygenation. Maul TM; Wolff EL; Kuch BA; Rosendorff A; Morell VO; Wearden PD Pediatr Crit Care Med; 2012 Nov; 13(6):e363-71. PubMed ID: 22940857 [TBL] [Abstract][Full Text] [Related]
15. Depressed cardiovascular function and altered platelet kinetics following protamine sulfate reversal of heparin activity. Wakefield TW; Whitehouse WM; Stanley JC J Vasc Surg; 1984 Mar; 1(2):346-55. PubMed ID: 6481883 [TBL] [Abstract][Full Text] [Related]
16. Application of a new anticoagulant (Nafamostat Mesilate) to control hemorrhagic complications during extracorporeal membrane oxygenation--a preliminary report. Nagaya M; Futamura M; Kato J; Niimi N; Fukuta S J Pediatr Surg; 1997 Apr; 32(4):531-5. PubMed ID: 9126748 [TBL] [Abstract][Full Text] [Related]
17. Toward a better understanding of the hemodynamic effects of protamine and heparin interaction. Stefaniszyn HJ; Novick RJ; Salerno TA J Thorac Cardiovasc Surg; 1984 May; 87(5):678-86. PubMed ID: 6717047 [TBL] [Abstract][Full Text] [Related]
18. Twenty-four-hour venoarterial extracorporeal membrane oxygenation without systemic heparinization in dogs. Miyasaka K; Takata M; Muto R Pediatr Surg Int; 1996 Aug; 11(7):466-70. PubMed ID: 24057784 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of a new heparin bonding process in prolonged extracorporeal membrane oxygenation. Nojiri C; Hagiwara K; Yokoyama K; Kurbayashi E; Hidaka K; Ishida N; Horiuchi K; Oshiyama H; Nogawa A; Kido T ASAIO J; 1995; 41(3):M561-7. PubMed ID: 8573868 [TBL] [Abstract][Full Text] [Related]
20. The hemodynamic effects of intra-aortic versus intravenous administration of protamine for reversal of heparin in pigs. Rogers K; Milne B; Salerno TA J Thorac Cardiovasc Surg; 1983 Jun; 85(6):851-5. PubMed ID: 6855256 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]